NetworkNewsBreaks – MustGrow Biologics Corp (CSE: MGRO) Appoints Senior Executive with Extensive Regulatory Prowess to Board of Directors

July 17, 2019 10:05:02

MustGrow Biologics (CSE: MGRO), an agricultural biotech company, this morning announced the appointment of Brian Quigley to its board of directors, subject to applicable regulatory approval. Quigley, a proven leader in navigating complex regulatory environments for novel and innovative products, brings to MustGrow a competitive strategic advantage with over 20 years of regulatory expertise, brand building, marketing and operations experience. Brian most recently spent 16 years at Altria Group, with seven of those as president and CEO for U.S. Smokeless Tobacco and Nu-Mark, Altria’s innovation company. “Brian brings extensive regulatory prowess, brand building and product innovation experience to MustGrow,” MGRO CEO Corey Giasson said in the news release. “His richly developed relationships in international food conglomerates, Big Tobacco and the cannabis community will spark powerful initiatives in all of MustGrow’s agriculture programs.”

To view the full press release, visit http://nnw.fm/h3RcY

About MustGrow Biologics Corp.

MustGrow is an agricultural biotech company focused on developing and commercializing its patented natural biologic product that acts as a pesticide, fungicide nematicide and fertilizer. Targeting the fruit, vegetable, turf, ornamentals and cannabis industries, MustGrow has designed a United States EPA-approved organic solution that uses the mustard seed’s natural defense mechanisms to protect plants from pests and diseases. Approximately $9 million has previously been spent on 110 independent tests, validating MustGrow’s remarkably safe and effective granular product. MustGrow’s granular product is EPA-approved across all key U.S. states as a fertilizer and pesticide (currently limited to fertilizer in California) and is designated by Health Canada’s PMRA (Pest Management Regulatory Agency) as a fruit, vegetable, turf and ornamental biopesticide and biofertilizer. In cannabis, MustGrow is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations. MustGrow is positioning its signature product as an effective pre-plant soil treatment, reducing the chance for any added soil to a greenhouse to bring in pests or diseases. MustGrow expects its biopesticide and biofertilizer will help licensed cannabis producers control the same conditions addressed in fruit and vegetable crops. For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://nnw.fm/MGRO

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]